Erratum: Genomic binding sites and biological effects of the vitamin D-VDR complex in multiple sclerosis (Neuromol Med DOI: 10.1007/s12017-014-8301-2);Genomic binding sites and biological effects of the vitamin D: VDR complex in multiple sclerosis

NeuroMolecular Medicine

Volumn 16, Issue 2, 2014, Pages 265-279

  Kalman, Bernadette ^a,b   Toldy, Erzsebet ^a,b  

^a UNIVERSITY OF PÉCS   (Hungary)

^b Markusovszky University Teaching Hospital   (Hungary)

Author keywords

Autoimmunity; Genomic binding sites; Multiple sclerosis; Transcriptional regulation; Vitamin D receptor

Indexed keywords

COLECALCIFEROL RECEPTOR; VITAMIN D; CALCITRIOL RECEPTOR; COLLAGENASE 3; DNA; FORKHEAD TRANSCRIPTION FACTOR; HLA DRB1 ANTIGEN; HLA-DRB1*15 ANTIGEN; MMP13 PROTEIN, HUMAN;

ARTICLE; BINDING SITE; COMPLEX FORMATION; DEMYELINATION; DOWN REGULATION; ENVIRONMENTAL FACTOR; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INTERACTION; GENE LOCUS; GENOME ANALYSIS; HUMAN; IMMUNOREGULATION; MOLECULAR DYNAMICS; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VDR GENE; ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; IMMUNOLOGY; INFLAMMATION; METABOLISM; PHYSIOLOGY;

ANIMALS; BINDING SITES; DNA; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HLA-DRB1 CHAINS; HUMANS; INFLAMMATION; MATRIX METALLOPROTEINASE 13; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCITRIOL; VITAMIN D;

EID: 84901357351     PISSN: 15351084     EISSN: 15591174     Source Type: Journal    
DOI: 10.1007/s12017-014-8304-z     Document Type: Erratum

References (90)

1. Achiron, A., Feldman, A., & Gurevich, M. (2011). Characterization of multiple sclerosis traits: Nuclear receptors (NR) impaired apoptosis pathway and the role of 1-α 25-dihydroxyvitamin D3. Journal of the Neurological Sciences, 311(1-2), 9-14.
2. Adorini, L., & Penna, G. (2009). Induction of tolerogenic dendritic cells by vitamin D receptor agonists. Handbook of Experimental Pharmacology, 188, 251-273.
3. Adzemovic, M. Z., Zeitelhofer, M., Hochmeister, S., Gustafsson, S. A., & Jagodic, M. (2013). Efficacy of vitamin D in treating multiple sclerosis-like neuroinflammation depends on developmental stage. Experimental Neurology, 249, 39-48.
4. Alroy, I., Towers, T. L., & Freedman, L. P. (1995). Transcriptional repression of the interleukin-2 gene by vitamin D3: Direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Molecular and Cellular Biology, 15(10), 5789-5799.
5. An, B. S., Tavera-Mendoza, L. E., Dimitrov, V., Wang, X., Calderon, M. R., Wang, H. J., et al. (2010). Stimulation of Sirt1-regulated FoxO protein function by the ligand-bound vitamin D receptor. Molecular and Cellular Biology, 30(20), 4890-4900.
6. Ascherio, A., & Munger, K. L. (2010). Epstein-barr virus infection and multiple sclerosis: A review. J Neuroimmune Pharmacol., 5(3), 271-277.
7. Ascherio, A., Munger, K. L., & Simon, K. C. (2010). Vitamin D and multiple sclerosis: Review. The Lancet Neurology, 9(6), 599-612.
8. Aslam, F., McCabe, L., Frenkel, B., van Wijnen, A. J., Stein, G. S., Lian, J. B., et al. (1999). AP-1 and vitamin D receptor (VDR) signaling pathways converge at the rat osteocalcin VDR element: Requirement for the internal activating protein-1 site for vitamin D-mediated trans-activation. Endocrinology, 140(1), 63-70.
9. Baranzini, S. E. (2011). Revealing the genetic basis of multiple sclerosis: Are we there yet? Current Opinion in Genetics & Development, 21(3), 317-324.
10. Baranzini, S. E., Galwey, N. W., Wang, J., Khankhanian, P., Lindberg, R., Pelletier, D., Wu, W., Uitdehaag, B. M., Kappos, L., GeneMSA Consortium, Polman, C. H., Matthews, P. M., Hauser, S. L., Gibson, R. A., Oksenberg, J. R., Barnes, M. R. (2009). Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Human Molecular Genetics, 18(11), 2078-2090.
11. Barreyro, F. J., Kobayashi, S., Bronk, S. F., Werneburg, N. W., Malhi, H., & Gores, G. J. (2007). Transcriptional regulation of Bim by FoxO3A mediates hepatocyte lipoapoptosis. Journal of Biological Chemistry, 282(37), 27141-27154.
12. Bernstein, B. E., Birney, E., Dunham, I., Green, E. D., Gunter, C., & Snyder, M. (2012). ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature, 489(7414), 57-74.
13. Brennan, A., Katz, D. R., Nunn, J. D., Barker, S., Hewison, M., Fraher, L. J., et al. (1987). Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol. Immunology, 61(4), 457-461.
14. Bruce, D., & Cantorna, M. T. (2011). Intrinsic requirement for the vitamin D receptor in the development of CD8αα-expressing T cells. J Immunol., 186(5), 2819-2825.
15. Cantorna, M. T., Hayes, C. E., & DeLuca, H. F. (1996). 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 93(15), 7861-7864.
16. Cantorna, M. T., Zhao, J., & Yang, L. (2012). Vitamin D, invariant natural killer T-cells and experimental autoimmune disease. The Proceedings of the Nutrition Society, 71(1), 62-66.
17. Chang, J. H., Cha, H. R., Lee, D. S., Seo, K. Y., & Kweon, M. N. (2010). 1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis. PLoS ONE, 5(9), e12925.
18. Chen, S., Sims, G. P., Chen, X. X., Gu, Y. Y., & Lipsky, P. E. (2007). Modulatory effects of 1,3-dihydroxyvitamin D3 on human B cell differentiation. Journal of Immunology, 179, 1634-1647.
19. Compston, A. (1999). The genetic epidemiology of multiple sclerosis. Philosophical Transactions of the Royal Society of London. Series B, Biological sciences, 354(1390), 1623-1634.
20. Daitoku, H., Hatta, M., Matsuzaki, H., Aratani, S., Ohshima, T., Miyagishi, M., et al. (2004). Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proceedings of the National Academy of Sciences of the United States of America, 101(27), 10042-10047.
21. Deluca, H. F., & Cantorna, M. T. (2001). Vitamin D: Its role and uses in immunology. FASEB Journal, 15(14), 2579-2585.
22. Dimitrov, V., Salehi-Tabar, R., An, B. S., & White, J. H. (2013). Non-classical mechanisms of transcriptional regulation by the vitamin D receptor: Insights into calcium homeostasis, immune system regulation and cancer chemoprevention. The Journal of Steroid Biochemistry and Molecular Biology. doi: 10.1016/j.jsbmb.2013.07.012.
23. Disanto, G., Morahan, J. M., Barnett, M. H., Giovannoni, G., & Ramagopalan, S. V. (2012a). The evidence for a role of B cells in multiple sclerosis. Neurology, 78(11), 823-832.
24. Disanto, G., Sandve, G. K., Berlanga-Taylor, A. J., Morahan, J. M., Dobson, R., Giovannoni, G., et al. (2012b). Genomic regions associated with multiple sclerosis are active in B cells. PLoS ONE, 7(3), e32281. doi: 10.1371/journal.pone.0032281.
25. Disanto, G., Sandve, G. K., Berlanga-Taylor, A. J., Ragnedda, G., Morahan, J. M., Watson, C. T., et al. (2012c). Vitamin D receptor binding, chromatin states and association with multiple sclerosis. Human Molecular Genetics, 21(16), 3575-3586.
26. Dörr, J., Döring, A., & Paul, F. (2013). Can we prevent or treat multiple sclerosis by individualised vitamin D supply? EPMA Journal, 4(1), 4. doi: 10.0086/1878-5085-4-4.
27. Dörr, J., Ohlraun, S., Skarabis, H., & Paul, F. (2012). Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): Study protocol for a randomized controlled trial. Trials, 13, 15.
28. Ernst, J., Kheradpour, P., Mikkelsen, T. S., Shoresh, N., Ward, L. D., Epstein, C. B., et al. (2011). Mapping and analysis of chromatin state dynamics in nine human cell types. Nature, 473(7345), 43-49.
29. Eyles, D., Almeras, L., Benech, P., Patatian, A., Mackay-Sim, A., McGrath, J., et al. (2007). Developmental vitamin D deficiency alters the expression of genes encoding mitochondrial, cytoskeletal and synaptic proteins in the adult rat brain. Journal of Steroid Biochemistry and Molecular Biology, 103(3-5), 538-545.
30. Garcia-Martin, E., Agundez, J. A., Martinez, C., Benito-Leon, J., Millan-Pacual, J., Calleja, P., et al. (2013). Vitamin D3 receptor (VDR) gene rs2228570 (Fok1) and rs731236 (Taq1) variants are not associated with the risk for multiple sclerosis: Results of a new study and a meta-analysis. PLoS ONE, 8(6), e65487. doi: 10.1371/journal.pone.0065487.
31. Grishkan, I. V., Fairchild, A. N., Calabresi, P. A., & Gocke, A. R. (2013). 1,25-Dihydroxyvitamin D3 selectively and reversibly impairs T helper-cell CNS localization. Proceedings of the National Academy of Sciences of the United States of America, 110(52), 21101-21106.
32. Hafler, D. A., Compston, A., Sawcer, S., Lander, E. S., Daly, M. J., De Jager, P. L., et al. (2007). Risk alleles for multiple sclerosis identified by a genomewide study. New England Journal of Medicine, 357, 851-862.
33. Handel, A. E., Sandve, G. K., Disanto, G., Berlanga-Taylor, A. J., Gallone, G., Hanwell, H., et al. (2013). Vitamin D receptor ChIP-seq in primary CD4+ cells: Relationship to serum 25-hydroxyvitamin D levels and autoimmune disease. BMC Medicine, 11, 163. doi: 10.1186/1741-7015-11-163.
34. Handunnetthi, L., Ramagopalan, S. V., & Ebers, G. C. (2010). Multiple sclerosis, vitamin D, and HLA-DRB1*15. Neurolog., 74(23), 1905-1910. doi: 10.1212/WNL.0b013e3181e24124.
35. Heikkinen, S., Väisänen, S., Pehkonen, P., Seuter, S., Benes, V., & Carlberg, C. (2011). Nuclear hormone 1α,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy. Nucleic Acids Research, 39(21), 9181-9193.
36. James, E., Dobson, R., Kuhle, J., Baker, D., Giovannoni, G., & Ramagopalan, S. V. (2013). The effect of vitamin D-related interventions on multiple sclerosis relapses: A meta-analysis. Multiple Sclerosis, 19(12), 1571-1579.
37. Joshi, S., Pantalena, L. C., Liu, X. K., Gaffen, S. L., Liu, H., Rohowsky-Kochan, C., et al. (2011). 1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Molecular and Cellular Biology, 31(17), 3653-3669.
38. Kim, M. S., Fujiki, R., Murayama, A., Kitagawa, H., Yamaoka, K., Yamamoto, Y., et al. (2007). 1Alpha,25(OH)2D3-induced transrepression by vitamin D receptor through E-box-type elements in the human parathyroid hormone gene promoter. Molecular Endocrinology, 21(2), 334-342.
39. Kim, S. Y., Herbst, A., Tworkowski, K. A., Salghetti, S. E., & Tansey, W. P. (2003). Skp2 regulates Myc protein stability and activity. Molecular Cell, 11(5), 1177-1188.
40. Knippenberg, S., Smolders, J., Thewissen, M., Peelen, E., Tervaert, J. W., Hupperts, R., et al. (2011). Effect of vitamin D(3) supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis. Multiple Sclerosis, 17(12), 1418-1423.
41. Kongsbak, M., Levring, T. B., Geisler, C., & von Essen, M. R. (2013). The vitamin d receptor and T cell function. Frontiers in Immunology, 4, 148. doi: 10.3389/fimmu.2013.00148.
42. Li, B., Baylink, D. J., Deb, C., Zannetti, C., Rajaallah, F., Xing, W., et al. (2013a). 1,25-Dihydroxyvitamin D3 suppresses TLR8 expression and TLR8-mediated inflammatory responses in monocytes in vitro and experimental autoimmune encephalomyelitis in vivo. PLoS ONE, 8(3), e58808. doi: 10.1371/journal.pone.0058808.
43. Li, Y. C., Chen, Y., Liu, W., & Thadhani, R. (2013b). MicroRNA-mediated mechanism of vitamin D regulation of innate immune response. The Journal of Steroid Biochemistry and Molecular Biology. doi: 10.1016/j.jsbmb.2013.09.014.
44. Lin, R., Wang, T. T., Miller, W. H, Jr, & White, J. H. (2003). Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells. Endocrinology, 144(3), 749-753.
45. Mayne, C. G., Spanier, J. A., Relland, L. M., Williams, C. B., & Hayes, C. E. (2011). 1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis. European Journal of Immunology, 41(3), 822-832.
46. Meyer, M. B., Benkusky, N. A., & Pike, J. W. (2013). 1,25-Dihydroxyvitamin D3 induced histone profiles guide discovery of VDR action sites. The Journal of Steroid Biochemistry and Molecular Biology. doi: 10.1016/j.jsbmb.2013.09.005.
47. Morán-Auth, Y., Penna-Martinez, M., Shoghi, F., Ramos-Lopez, E., & Badenhoop, K. (2013). Vitamin D status and gene transcription in immune cells. Journal of Steroid Biochemistry and Molecular Biology, 136, 83-85. doi: 10.1016/j.jsbmb.2013.02.005.
48. Morin, P. J. (1999). Beta-catenin signaling and cancer. BioEssays, 21(12), 1021-1030.
49. Murayama, A., Kim, M. S., Yanagisawa, J., Takeyama, K., & Kato, S. (2004). Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching. EMBO Journal, 23(7), 1598-1608.
50. Nashold, F. E., Miller, D. J., & Hayes, C. E. (2000). 1,25-dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis. Journal of Neuroimmunology, 103(2), 171-179.
51. Nashold, F. E., Nelson, C. D., Brown, L. M., & Hayes, C. E. (2013). One calcitriol dose transiently increases Helios+ FoxP3+ T cells and ameliorates autoimmune demyelinating disease. Journal of Neuroimmunology, 263(1-2), 64-74.
52. Palmer, H. G., González-Sancho, J. M., Espada, J., Berciano, M. T., Puig, I., Baulida, J., et al. (2001). Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. Journal of Cell Biology, 154(2), 369-387.
53. Ramagopalan, S. V., Dyment, D. A., Cader, M. Z., Morrison, K. M., Disanto, G., Morahan, J. M., et al. (2011). Rare variants in the CYP27B1 gene are associated with multiple sclerosis. Annals of Neurology, 70(6), 881-886.
54. Ramagopalan, S. V., Heger, A., Berlanga, A. J., Maugeri, N. J., Lincoln, M. R., Burrell, A., et al. (2010). A ChIP-seq defined genome-wide map of vitamin D receptor binding: Associations with disease and evolution. Genome Research, 20(10), 1352-1360.
55. Ramagopalan, S. V., Lee, J. D., Yee, I. M., Guimond, C., Traboulsee, A. L., Ebers, G. C., et al. (2013). Association of smoking with risk of multiple sclerosis: A population-based study. Journal of Neurology, 260(7), 1778-1781.
56. Ramagopalan, S. V., Maugeri, N. J., Handunnetthi, L., Lincoln, M. R., Orton, S. M., Dyment, D. A., et al. (2009). Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genetics, 5(2), e1000369. doi: 10.1371/journal.pgen.1000369.
57. Salehi-Tabar, R., Nguyen-Yamamoto, L., Tavera-Mendoza, L. E., Quail, T., Dimitrov, V., An, B. S., et al. (2012). Vitamin D receptor as a master regulator of the c-MYC/MXD1 network. Proceedings of the National Academy of Sciences of the United States of America, 109(46), 18827-18832.
58. Salzer, J., & Sundström, P. (2013). Timing of cigarette smoking as a risk factor for multiple sclerosis. Therapeutic Advances in Neurological Disorders, 6(3), 205.
59. Sanseverino, I., Rinaldi, A. O., Purificato, C., Cortese, A., Millefiorini, E., Gessani, S., & Gauzzi, M. C. (2013). CCL2 induction by 1,25(OH)2D3 in dendritic cells from healthy donors and multiple sclerosis patients. The Journal of Steroid Biochemistry and Molecular Biology. doi: 10.1016/j.jsbmb.2013.10.018.
60. Satoh, J., & Tabunoki, H. (2013). Molecular network of chromatin immunoprecipitation followed by deep sequencing-based vitamin D receptor target genes. Multiple Sclerosis, 19(8), 1035-1045.
61. Schmidt, M., Fernandez de Mattos, S., van der Horst, A., Klompmaker, R., Kops, G. J., Lam, E. W., et al. (2002). Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. Molecular and Cellular Biology, 22(22), 7842-7852.
62. Seuter, S., Heikkinen, S., & Carlberg, C. (2013). Chromatin acetylation at transcription start sites and vitamin D receptor binding regions relates to effects of 1α,25-dihydroxyvitamin D3 and histone deacetylase inhibitors on gene expression. Nucleic Acids Research, 41(1), 110-124.
63. Shah, S., Hecht, A., Pestell, R., & Byers, S. W. (2003). Trans-repression of beta-catenin activity by nuclear receptors. Journal of Biological Chemistry, 278(48), 48137-48145.
64. Shah, S., Islam, M. N., Dakshanamurthy, S., Rizvi, I., Rao, M., Herrell, R., et al. (2006). The molecular basis of vitamin D receptor and beta-catenin crossregulation. Molecular Cell, 21(6), 799-809.
65. Simon, K. C., Munger, K. L., & Ascherio, A. (2012). Vitamin D and multiple sclerosis: Epidemiology, immunology, and genetics. Current Opinion in Neurology, 25(3), 246-251.
66. Simon, K. C., Munger, K. L., Yang, Xing, & Ascherio, A. (2010a). Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis. Multiple Sclerosis, 16(2), 133-138.
67. Simon, K. C., van der Mei, I. A., Munger, K. L., Ponsonby, A., Dickinson, J., Dwyer, T., et al. (2010b). Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk. Neurology., 74(17), 1365-1371.
68. Sloka, S., Silva, C., Wang, J., & Yong, V. W. (2011). Predominance of Th2 polarization by vitamin D through a STAT6-dependent mechanism. J Neuroinflammation., 8, 56. doi: 10.1186/1742-2094-8-56.
69. Smolders, J., & Damoiseaux, J. (2011). Vitamin D as a T-cell modulator in multiple sclerosis. Vitamins and Hormones, 86, 401-428.
70. Smolders, J., Damoiseaux, J., Menheere, P., Tervaert, J. W., & Hupperts, R. (2009). Association study on two vitamin D receptor gene polymorphisms and vitamin D metabolites in multiple sclerosis. Annals of the New York Academy of Sciences, 1173, 515-520. doi: 10.1111/j.1749-6632.2009.04656.x.
71. Smolders, J., Hupperts, R., Barkhof, F., Grimaldi, L. M., Holmoy, T., Killestein, J., et al. (2011). Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial. Journal of the Neurological Sciences, 311(1-2), 44-49.
72. Smolders, J., Peelen, E., Thewissen, M., Menheere, P., Damoiseaux, J., & Hupperts, R. (2014). Circulating vitamin D binding protein levels are not associated with relapses or with vitamin D status in multiple sclerosis. Multiple Sclerosis, 20(4), 433-437.
73. Smolders, J., Schuurman, K. G., van Strien, M. E., Melief, J., Hendrickx, D., Hol, E. M., et al. (2013). Expression of vitamin D receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue. Journal of Neuropathology and Experimental Neurology, 72(2), 91-105.
74. Spach, K. M., Pedersen, L. B., Nashold, F. E., Kayo, T., Yandell, B. S., Prolla, T. A., et al. (2004). Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis. Physiological Genomics, 18(2), 141-151.
75. 3-mediated reduction of the pathogenic T cell burden in the central nervous system in experimental autoimmune encephalomyelitis, a multiple sclerosis model. Journal of Immunology, 189(6), 3188-3197.
76. Tajouri, L., Ovcaric, M., Curtain, R., Johnson, M. P., Griffiths, L. R., Csurhes, P., et al. (2005). Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population. Journal of Neurogenetics, 19(1), 25-38.
77. The International Multiple Sclerosis Consortium. (2013b). Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nature Genetics, 45(11), 1353-1360.
78. The International Multiple Sclerosis Consortium and the Wellcome Trust Case Control Consortium 2. (2011). Genetic risk and a primary role for cell-mediated immune mechanism in multiple sclerosis. Nature, 476, 214-218.
79. The International Multiple Sclerosis Genetics Consortium. (2013a). Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls. American Journal of Human Genetics, 92, 1-12.
80. Towers, T. L., & Freedman, L. P. (1998). Granulocyte-macrophage colony-stimulating factor gene transcription is directly repressed by the vitamin D3 receptor. Implications for allosteric influences on nuclear receptor structure and function by a DNA element. Journal of Biological Chemistry, 273(17), 10338-10348.
81. Tuller, T., Atar, S., Ruppin, E., Gurevich, M., & Achiron, A. (2013). Common and specific signatures of gene expression and protein-protein interactions in autoimmune diseases. Genes and Immunity, 14(2), 67-82.
82. van Etten, E., & Mathieu, C. (2005). Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts. The Journal of Steroid Biochemistry and Molecular Biology, 97(1-2), 93-101.
83. Verstuyf, A., Carmeliet, G., Bouillon, R., & Mathieu, C. (2010). Vitamin D: A pleiotropic hormone. Kidney International, 78, 140-145.
84. Verway, M., Bouttier, M., Wang, T. T., Calderon, M., An, B. S., Devemy, E., Mcintosh, F., Divangahi, M., Behr, M. A., & White, J. H. (2013). Vitamin D induces interleukin-1β expression: Paracrine macrophage epithelial signaling controls M. tuberculosis infection. PLOS Pathogens. doi: 10.1371/journal.ppat.1003407.
85. Virtanen, J. O., & Jacobson, S. (2012). Viruses and multiple sclerosis. CNS & Neurological Disorders: Drug Targets, 11(5), 528-544.
86. von der Lehr, N., Johansson, S., Wu, S., Bahram, F., Castell, A., Cetinkaya, C., et al. (2003). The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Molecular Cell, 11(5), 1189-1200.
87. von Essen, M. R., Kongsbak, M., Schjerling, P., Olgaard, K., Odum, N., & Geisler, C. (2010). Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nature Immunology, 11(4), 344-349.
88. Willer, C. J., Dyment, D. A., Risch, N. J., Sadovnick, A. D., & Ebers, G. C. (2003). Twin concordance and sibling recurrence rates in multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 100(22), 12877-12882.
89. Yu, S., Bruce, D., Froicu, M., Weaver, V., & Cantorna, M. T. (2008). Failure of T cell homing, reduced CD4/CD8alphaalpha intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice. Proceedings of the National Academy of Sciences of the United States of America, 105(52), 20834-20839.
90. Zittermann, A., Tenderich, G., & Koerfer, R. (2009). Vitamin D and the adaptive immune system with special emphasis to allergic reactions and allograft rejection. Inflammation & Allergy: Drug Targets, 8(2), 161-168.